0002080612-26-000043.txt : 20260710 0002080612-26-000043.hdr.sgml : 20260710 20260710093419 ACCESSION NUMBER: 0002080612-26-000043 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260710 DATE AS OF CHANGE: 20260710 EFFECTIVENESS DATE: 20260710 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vantis Vascular, Inc. CENTRAL INDEX KEY: 0001761882 ORGANIZATION NAME: EIN: 823343057 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-590303 FILM NUMBER: 261167145 BUSINESS ADDRESS: STREET 1: 2570 N 1ST STREET STREET 2: SUITE 200 CITY: SAN JOSE STATE: CA ZIP: 95131 BUSINESS PHONE: 833-852-3001 MAIL ADDRESS: STREET 1: 2570 N 1ST STREET STREET 2: SUITE 200 CITY: SAN JOSE STATE: CA ZIP: 95131 FORMER COMPANY: FORMER CONFORMED NAME: CrossLiner, Inc. DATE OF NAME CHANGE: 20181214 D 1 primary_doc.xml X0708 D LIVE 0001761882 Vantis Vascular, Inc. 2570 N 1ST STREET SUITE 200 SAN JOSE CA CALIFORNIA 95131 833-852-3001 DELAWARE CrossLiner, Inc. Corporation true Tim Fischell c/o Vantis Vascular, Inc. 2570 N First Street, Suite 200 San Jose CA CALIFORNIA 95131 Executive Officer Director Frank Saltiel c/o Vantis Vascular, Inc. 2570 N First Street, Suite 200 San Jose CA CALIFORNIA 95131 Executive Officer Director Len Pinchuk c/o Vantis Vascular, Inc. 2570 N First Street, Suite 200 San Jose CA CALIFORNIA 95131 Director Jason Turner c/o Vantis Vascular, Inc. 2570 N First Street, Suite 200 San Jose CA CALIFORNIA 95131 Executive Officer Director Marc Monahan c/o Vantis Vascular, Inc. 2570 N First Street, Suite 200 San Jose CA CALIFORNIA 95131 Executive Officer Mike Mirizzi c/o Vantis Vascular, Inc. 2570 N First Street, Suite 200 San Jose CA CALIFORNIA 95131 Executive Officer Gary McCord c/o Vantis Vascular, Inc. 2570 N First Street, Suite 200 San Jose CA CALIFORNIA 95131 Executive Officer Other Decline to Disclose 06b false 2026-06-26 false true true true false 0 21500000 18639500 2860500 Of the total amount sold, $8,639,500 relates to new money investments, and $10,000,000 relates to shares issued for the conversion of SAFEs. The amount sold does not include up to $1,295,924 to be received upon exercise of warrants issued in the offering. false 123 0 0 0 false Vantis Vascular, Inc. /s/ Phillip Torrence Phillip Torrence Secretary 2026-07-10